Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates

J Clin Microbiol. 2008 Jun;46(6):2028-37. doi: 10.1128/JCM.00818-07. Epub 2008 Mar 5.

Abstract

The emergence of metallo-beta-lactamase (MBL)-producing isolates is a challenge to routine microbiology laboratories, since there are no standardized methods for detecting such isolates. The aim of this study was to evaluate the accuracy of different phenotypic methods to detect MBL production among Pseudomonas spp., Acinetobacter spp., and enterobacterial isolates, including GIM, IMP, SIM, SPM, and VIM variants. A total of 46 genetically unrelated Pseudomonas aeruginosa, Pseudomonas putida, Acinetobacter sp., and enterobacterial strains producing distinct MBLs were tested. Nineteen strains were included as negative controls. The inhibition of bacterial growth and beta-lactam hydrolysis caused by MBL inhibitors (IMBL) also were evaluated. The isolates were tested for MBL production by both a double-disk synergy test (DDST) and a combined disk assay (CD) using imipenem and ceftazidime as substrates in combination with distinct IMBL. One hundred percent sensitivity and specificity were achieved by DDST using 2-mercaptopropionic acid in combination with ceftazidime and imipenem for the detection of MBL production among P. aeruginosa and Acinetobacter species isolates, respectively. The CD test showed the same results for detecting MBL-producing enterobacteria by combining imipenem and EDTA, with a 5.0-mm-breakpoint increase in the size of the inhibition zone. Our results indicate that both phenotypic methods to detect MBL-producing isolates should be based on the genera to be tested, regardless of the enzyme produced by such isolates, as well as on the local prevalence of MBL producers.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter* / classification
  • Acinetobacter* / drug effects
  • Acinetobacter* / enzymology
  • Acinetobacter* / isolation & purification
  • Anti-Bacterial Agents / pharmacology*
  • Disk Diffusion Antimicrobial Tests / methods
  • Disk Diffusion Antimicrobial Tests / standards
  • Drug Resistance, Bacterial
  • Enterobacteriaceae* / classification
  • Enterobacteriaceae* / drug effects
  • Enterobacteriaceae* / enzymology
  • Enterobacteriaceae* / isolation & purification
  • Humans
  • Microbial Sensitivity Tests / methods
  • Microbial Sensitivity Tests / standards
  • Phenotype
  • Pseudomonas* / classification
  • Pseudomonas* / drug effects
  • Pseudomonas* / enzymology
  • Pseudomonas* / isolation & purification
  • beta-Lactamases / biosynthesis*

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases